Do we need biopsies of metastases for colorectal cancer patients?

Por Floriani, I, Santini, D, Torri, V, Cremolini, C, Falcone, A, Loupakis, F
Publicado em 2009

Biological Characteristics and Medical Treatment of Breast Cancer in Young Women—A Featured Population: Results from the NORA Study

Por Pronzato, P., Mustacchi, G., De Matteis, A., Di Costanzo, F., Rulli, E., Floriani, I., Cazzaniga, M. E.
Publicado em 2011

Randomised controlled trial comparing single agent paclitaxel vs epidoxorubicin plus paclitaxel in patients with advanced ovarian cancer in early progression after platinum-based c...

Por Buda, A, Floriani, I, Rossi, R, Colombo, N, Torri, V, Conte, P F, Fossati, R, Ravaioli, A, Mangioni, C
Publicado em 2004

Randomised study of systematic lymphadenectomy in patients with epithelial ovarian cancer macroscopically confined to the pelvis

Por Maggioni, A, Benedetti Panici, P, Dell'Anna, T, Landoni, F, Lissoni, A, Pellegrino, A, Rossi, R S, Chiari, S, Campagnutta, E, Greggi, S, Angioli, R, Manci, N, Calcagno, M, Scambia, G, Fossati, R, Floriani, I, Torri, V, Grassi, R, Mangioni, C
Publicado em 2006

KRAS codon 61, 146 and BRAF mutations predict resistance to cetuximab plus irinotecan in KRAS codon 12 and 13 wild-type metastatic colorectal cancer

Por Loupakis, F, Ruzzo, A, Cremolini, C, Vincenzi, B, Salvatore, L, Santini, D, Masi, G, Stasi, I, Canestrari, E, Rulli, E, Floriani, I, Bencardino, K, Galluccio, N, Catalano, V, Tonini, G, Magnani, M, Fontanini, G, Basolo, F, Falcone, A, Graziano, F
Publicado em 2009